SEC Form 4 · accession 0001615774-18-002939
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald Eric D'Ambrosio
Officer — Chief Financial Officer
Period of report
Apr 4, 2018
Accepted (ET)
Apr 26, 2018 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to purchase)F1 | $1.55 | Apr 4, 2018 | A | 18,000 | A | Apr 4, 2018 | Apr 4, 2028 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1On April 4, 2018, the reporting person was granted an option to purchase 18,000 shares of common stock. The option vests in four equal installments based on the reporting person's satisfaction of certain performance criteria. Three of the four milestones have been satisfied.